PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researcher to present discoveries on medical uses of ultrasound to London's Royal Society

2011-04-20
(Press-News.org) Jamie Tyler, assistant professor in the Virginia Tech Carilion Research Institute and the Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, has been invited to speak at a Royal Society of London high level workshop on May 11-12 on the security implications of advances in neuroscience.

The workshop is part of a four-part policy study on neuroscience and society called Brain Waves. This third module, entitled Neuroscience, conflict and security (http://royalsociety.org/brainwaves-security/), focuses on the international security implications and associated policy issues related to applications of advances in neuroscience and neurotechnology to the enhancement, manipulation, or degradation of human performance. The project is overseen by a Royal Society Working Group.

The technical sessions of the roundtable will focus on neuropharmacology, functional neuroimaging, and neural interfaces. As part of the the Mind Machine Interface session, Tyler will speak on the potential medical uses and concerns regarding emerging technologies for selectively activating or inactivating populations of dysfunctional nerve cells within the brain in order to develop effective non-invasive therapies for treatment of neurological and psychiatric disorders , such as ultrasound and transcranial magnetic stimulation.

"These are important discussions about mechanisms, applications, safety and policies around powerful new approaches for modulating electrical activity in the brain. This is an emerging area of interest at the interface of science and society and we are enthusiastic to have one of our leading biomedical researchers in neurotechnology, Dr. Tyler, playing a key role in this dialogue," said Michael Friedlander, director of the Virginia Tech Carilion Research Institute.

### END


ELSE PRESS RELEASES FROM THIS DATE:

Celebrate Easter Lunch or Dinner at Chef Point Cafe

Celebrate Easter Lunch or Dinner at Chef Point Cafe
2011-04-20
Chef Point Cafe is one Fort Worth Restaurant that will be serving up Easter dinner with flair this year. This gas station eatery has an Easter special menu just for Sunday with a limited version of it being served on Good Friday. The Grilled Australian Lamb Lollipops may go down as the Easter favorite but soups, salads and more will be available to tempt taste buds too. Celebrate the spring season with a special meal on a special day this Easter. What is Easter all about? Family? Friends? Forgiveness? At this Fort Worth restaurant, it is about all three. Celebrate the ...

Rational, emotional reasons guide genetic-testing choices

2011-04-20
Consumers decide whether to use mail-in genetic tests based on both rational and emotional reasons, a finding that adds to a growing body of health-care behavior research on information seeking and avoidance, according to researchers at the University of California, Riverside. In a study of what motivates or discourages consumers from participating in direct-to-consumer (DTC) genetic testing, UC Riverside psychologists found that potential users of the tests were influenced by perceived benefits and barriers to testing, and anticipated regret over testing versus not testing. "We ...

NJIT professor develops a biologically inspired catalyst, an active yet inert material

2011-04-20
NJIT Associate Professor Sergiu M. Gorun is leading a research team to develop biologically-inspired catalysis active, yet inert, materials. The work is based on organic catalytic framework made sturdy by the replacement of carbon-hydrogen bonds with a combination of aromatic and aliphatic carbon-fluorine bonds. Graduate students involved with this research recently received first place recognition at the annual NJIT Dana Knox student research showcase. http://www.njit.edu/news/2011/2011-101.php The newest focus of Gorun's research has been the cobalt complex as a ...

Hundreds of barrier islands newly identified in global survey

2011-04-20
DURHAM, N.C. -- Earth has 657 more barrier islands than previously thought, according to a new global survey by researchers from Duke University and Meredith College. The researchers identified a total of 2,149 barrier islands worldwide using satellite images, topographical maps and navigational charts. The new total is significantly higher than the 1,492 islands identified in a 2001 survey conducted without the aid of publicly available satellite imagery. All told, the 2,149 barrier islands measure 20,783 kilometers in length, are found along all continents except ...

How American consumers view debt: a case study

2011-04-20
CORVALLIS, Ore. – A new study published this month suggests that while younger Americans are more smitten with credit cards and debt than older Americans, the older generation helps enable their children by encouraging use of credit as a "safety mechanism." The findings were based on case studies conducted with 27 white, middle-class Americans in 2006. The researchers, Michelle Barnhart of Oregon State University and Lisa Peñaloza of Ecole des Hautes Etudes Commerciales du Nord of France, wanted to explore some of the attitudes, perceptions and cultural meanings behind ...

Exploiting the stress response to detonate mitochondria in cancer cells

2011-04-20
Researchers at The Wistar Institute have found a new way to force cancer cells to self-destruct. Low doses of one anti-cancer drug currently in development, called Gamitrinib, sensitize tumor cells to a second drug, called TRAIL, also currently in clinical development as part of an anticancer regimen. Their findings, published in the April issue of the Journal for Clinical Investigation, show how this combination approach kills tumor cells in both mouse models of glioblastoma and human glioblastoma cells. Glioblastomas are the most common and aggressive form ...

Limitations of question about race can create inaccurate picture of health-care disparities

2011-04-20
What race best describes your background? That one question, which appears on most paperwork for health care, could leave entire groups of people underserved and contribute to racial health disparities, according to new research from Rice University published in the current issue of the journal Demography. Medical forms that ask patients to identify a single race can alter patterns of racial health disparities because some multiracial adults identify with single-race groups whose health experience is different from their own. The researchers found that placing multiracial ...

First patient treated in European cardioprotection phase III trial with NeuroVive's CicloMulsion

2011-04-20
Lund Sweden — April 19, 2011 — NeuroVive Pharmaceutical and Hospices Civils de Lyon (HCL) today announced the enrollment and treatment of the first patient in the European multicenter trial of myocardial infarction (the CIRCUS study). NeuroVive's advanced CicloMulsion(TM) cremophor-free IV cyclosporine formulation is used in this study of 1,000 patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction to examine cyclosporine's ability to protect cardiac tissue. The double-blind, placebo-controlled, investigator-initiated study is being ...

LED efficiency puzzle solved by UC Santa Barbara theorists

2011-04-20
(Santa Barbara, Calif., April 19, 2011) -- Researchers at the University of California, Santa Barbara, say they've figured out the cause of a problem that's made light-emitting diodes (LEDs) impractical for general lighting purposes. Their work will help engineers develop a new generation of high-performance, energy-efficient lighting that could replace incandescent and fluorescent bulbs. "Identifying the root cause of the problem is an indispensable first step toward devising solutions," says Chris Van de Walle, a professor in the Materials Department at UC Santa Barbara ...

Biophysicist targeting IL-6 to halt breast, prostate cancer

Biophysicist targeting IL-6 to halt breast, prostate cancer
2011-04-20
An Ohio State biophysicist used a supercomputer to search thousands of molecular combinations for the best configuration to block a protein that can cause breast or prostate cancer. Chenglong Li, Ph.D., an assistant professor of medicinal chemistry and pharmacognosy at The Ohio State University (OSU), is leveraging a powerful computer cluster at the Ohio Supercomputer Center (OSC) to develop a drug that will block the small protein molecule Interleukin-6 (IL-6). The body normally produces this immune-response messenger to combat infections, burns, traumatic injuries, ...

LAST 30 PRESS RELEASES:

Fig trees convert atmospheric CO2 to stone

Intra-arterial tenecteplase for acute stroke after successful endovascular therapy

Study reveals beneficial microbes that can sustain yields in unfertilized fields

Robotic probe quickly measures key properties of new materials

Climate change cuts milk production, even when farmers cool their cows

Frozen, but not sealed: Arctic Ocean remained open to life during ice ages

Some like it cold: Cryorhodopsins

Demystifying gut bacteria with AI

Human wellbeing on a finite planet towards 2100: new study shows humanity at a crossroads

Unlocking the hidden biodiversity of Europe’s villages

Planned hydrogen refuelling stations may lead to millions of euros in yearly losses

Planned C-sections increase the risk of certain childhood cancers

Adults who have survived childhood cancer are at increased risk of severe COVID-19

Drones reveal extreme coral mortality after bleaching

New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia

Native habitats hold the key to the much-loved smashed avocado’s future

Using lightning to make ammonia out of thin air

Machine learning potential-driven insights into pH-dependent CO₂ reduction

Physician associates provide safe care for diagnosed patients when directly supervised by a doctor

How game-play with robots can bring out their human side

Asthma: patient expectations influence the course of the disease

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

Flexible, eco-friendly electronic plastic for wearable tech, sensors

Can the Large Hadron Collider snap string theory?

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

Synthetic DNA nanoparticles for gene therapy

New model to find treatments for an aggressive blood cancer

Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support

[Press-News.org] Researcher to present discoveries on medical uses of ultrasound to London's Royal Society